Exploring the Associations Between CHRNA5 and IREB2 Gene Polymorphisms and COPD in the Kazakhstan Population

<b>Background/Objectives</b>: Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterized by irreversible airway obstruction. This study aims to investigate the associations between COPD and its phenotypes with polymorphic variants of the <i>IREB2</i> and <i>CHRNA5</i> genes in the Kazakhstan population. <b>Methods</b>: A case-control study was conducted involving 265 COPD patients and 267 controls. Genotyping of the <i>IREB2</i> polymorphisms <i>rs13180</i> and <i>rs2568494</i>, as well as <i>CHRNA5 rs16969968</i> polymorphism, was performed using real-time polymerase chain reactions (Real-Time PCRs). <b>Results</b>: A higher frequency of the AA genotype of the <i>IREB2 rs2568494</i> polymorphism was identified in COPD patients with moderate to very severe airflow obstruction (Chronic Obstructive Lung Disease (GOLD) stages II, III, and IV), with an odds ratio of 0.69 (95% CI = 0.23-2.10; Padj = 0.03). The <i>IREB2 rs13180</i> polymorphism was significantly more frequent or prevalent in smokers and showed a correlation with FEV<sub>1</sub> (forced expiratory volume in one second) (β = 7.79, SE = 2.98, <i>p</i> = 0.01) and FEV<sub>1</sub>/ FVC (forced vital capacity) (β = 9.51, SE = 2.95, <i>p</i> = 0.002). Additionally, the CC genotype of this polymorphism was associated with clinical manifestations of COVID-19 in COPD patients (χ<sup>2</sup>= 3,95, df = 2, <i>p</i> = 0.05). <b>Conclusions</b>: Our study identified a significant association between the <i>IREB2 rs2568494</i> polymorphism and an increased risk of severe COPD. The <i>IREB2 rs13180</i> polymorphism was linked to smoking behavior, as well as key lung function indicators, suggesting its potential role in disease progression and lung damage. Furthermore, the CC genotype of the <i>IREB2 rs13180</i> polymorphism was associated with clinical manifestations of COVID-19 in COPD patients, indicating a potential impact of this genetic variant on susceptibility to viral infections in this population.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2025-09-13
DOI
https://doi.org/10.3390/biomedicines13092260
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the Associations Between CHRNA5 and IREB2 Gene Polymorphisms and COPD in the Kazakhstan Population

Gulnaza Idrisova, Yeldar Ashirbekov, Gaukhar Kurmanova, Almira Akparova et al.
Biomedicines
Influenza Virus Research Studies
article

Exploring the Associations Between CHRNA5 and IREB2 Gene Polymorphisms and COPD in the Kazakhstan Population

Gulnaza Idrisova, Yeldar Ashirbekov, Gaukhar Kurmanova, Almira Akparova, Аlmagul Kurmanova, Gulzhan Trimova, Balkiya Abdrakhmanova, Anarkul Kulembayeva, Diana Nigmatova, Zhanar Mussagulova
article en

Abstract

<b>Background/Objectives</b>: Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterized by irreversible airway obstruction. This study aims to investigate the associations between COPD and its phenotypes with polymorphic variants of the <i>IREB2</i> and <i>CHRNA5</i> genes in the Kazakhstan population. <b>Methods</b>: A case-control study was conducted involving 265 COPD patients and 267 controls. Genotyping of the <i>IREB2</i> polymorphisms <i>rs13180</i> and <i>rs2568494</i>, as well as <i>CHRNA5 rs16969968</i> polymorphism, was performed using real-time polymerase chain reactions (Real-Time PCRs). <b>Results</b>: A higher frequency of the AA genotype of the <i>IREB2 rs2568494</i> polymorphism was identified in COPD patients with moderate to very severe airflow obstruction (Chronic Obstructive Lung Disease (GOLD) stages II, III, and IV), with an odds ratio of 0.69 (95% CI = 0.23-2.10; Padj = 0.03). The <i>IREB2 rs13180</i> polymorphism was significantly more frequent or prevalent in smokers and showed a correlation with FEV<sub>1</sub> (forced expiratory volume in one second) (β = 7.79, SE = 2.98, <i>p</i> = 0.01) and FEV<sub>1</sub>/ FVC (forced vital capacity) (β = 9.51, SE = 2.95, <i>p</i> = 0.002). Additionally, the CC genotype of this polymorphism was associated with clinical manifestations of COVID-19 in COPD patients (χ<sup>2</sup>= 3,95, df = 2, <i>p</i> = 0.05). <b>Conclusions</b>: Our study identified a significant association between the <i>IREB2 rs2568494</i> polymorphism and an increased risk of severe COPD. The <i>IREB2 rs13180</i> polymorphism was linked to smoking behavior, as well as key lung function indicators, suggesting its potential role in disease progression and lung damage. Furthermore, the CC genotype of the <i>IREB2 rs13180</i> polymorphism was associated with clinical manifestations of COVID-19 in COPD patients, indicating a potential impact of this genetic variant on susceptibility to viral infections in this population.

BiomedicinesVol. 13(9)
L. N. Gumilyov Eurasian National University (KZ), Al-Farabi Kazakh National University (KZ), Institute of Plant Biology and Biotechnology (KZ), City Clinical Hospital (RU)
Al-Farabi Kazakh National University
Openalex Percentile: Top 66%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.